美年健康
(002044)
| 流通市值：198.27亿 | | | 总市值：200.41亿 |
| 流通股本：38.72亿 | | | 总股本：39.14亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 7,140,540,911.69 | 4,205,187,220.8 | 1,801,337,075.22 | 10,893,535,007.49 |
| 营业收入 | 7,140,540,911.69 | 4,205,187,220.8 | 1,801,337,075.22 | 10,893,535,007.49 |
| 二、营业总成本 | 6,938,686,419.55 | 4,379,292,978.14 | 2,107,445,751.54 | 9,995,374,869.11 |
| 营业成本 | 4,307,721,776.06 | 2,705,906,975.07 | 1,296,222,659.5 | 6,232,314,171.75 |
| 税金及附加 | 3,229,747.69 | 2,280,332.93 | 1,046,807.78 | 6,484,387.86 |
| 销售费用 | 1,717,818,887.17 | 1,076,066,714.49 | 512,924,249.21 | 2,562,904,527.26 |
| 管理费用 | 638,778,802.48 | 416,832,558.53 | 209,582,749.67 | 831,999,131.98 |
| 研发费用 | 37,492,770.55 | 25,544,147.29 | 13,166,822.94 | 62,649,103.69 |
| 财务费用 | 233,644,435.6 | 152,662,249.83 | 74,502,462.44 | 299,023,546.57 |
| 其中:利息费用 | 238,382,107.66 | 157,648,141.85 | 77,829,061.98 | 303,676,769.47 |
| 其中:利息收入 | 10,118,380.08 | 8,105,633.52 | 4,965,522.91 | 14,053,986.4 |
| 加:公允价值变动收益 | 1,433,500.9 | -6,287,006.83 | 1,031,655.09 | 41,902,536.02 |
| 加:投资收益 | -9,295,368.52 | -15,752,597.45 | -8,298,436.14 | 7,577,768.84 |
| 资产处置收益 | -6,773,287.36 | -2,958,523.17 | -492,740.5 | -6,894,558.26 |
| 资产减值损失(新) | -564,887.75 | -322,793 | -237,756.13 | -88,787,158.43 |
| 信用减值损失(新) | -101,816,853.71 | -47,778,439.23 | -23,816,348.92 | 8,518,225.96 |
| 其他收益 | 14,416,271.98 | 7,964,493.18 | 6,296,773.4 | 23,228,446.87 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 99,253,867.68 | -239,240,623.84 | -331,625,529.52 | 883,705,399.38 |
| 加:营业外收入 | 4,326,096.29 | 3,570,238.37 | 1,686,245.31 | 5,690,171.93 |
| 减:营业外支出 | 14,674,122.62 | 11,855,817.54 | 4,712,134.83 | 41,340,248.09 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 88,905,841.35 | -247,526,203.01 | -334,651,419.04 | 848,055,323.22 |
| 减:所得税费用 | 8,364,214.61 | -38,441,461.61 | -25,336,918.85 | 179,231,846.79 |
| 六、净利润 | 80,541,626.74 | -209,084,741.4 | -309,314,500.19 | 668,823,476.43 |
| 持续经营净利润 | 80,541,626.74 | -209,084,741.4 | -309,314,500.19 | 668,823,476.43 |
| 归属于母公司股东的净利润 | 24,632,532.07 | -215,777,193.4 | -286,618,131.63 | 505,621,135.98 |
| 少数股东损益 | 55,909,094.67 | 6,692,452 | -22,696,368.56 | 163,202,340.45 |
| (一)基本每股收益 | 0.01 | -0.06 | -0.07 | 0.13 |
| (二)稀释每股收益 | 0.01 | -0.06 | -0.07 | 0.13 |
| 八、其他综合收益 | -117,911.1 | 750,889.73 | -379,156.94 | 231,195.48 |
| 归属于母公司股东的其他综合收益 | -70,090.62 | 701,029.75 | -384,750.24 | 121,362.31 |
| 九、综合收益总额 | 80,423,715.64 | -208,333,851.67 | -309,693,657.13 | 669,054,671.91 |
| 归属于母公司股东的综合收益总额 | 24,562,441.45 | -215,076,163.65 | -287,002,881.87 | 505,742,498.29 |
| 归属于少数股东的综合收益总额 | 55,861,274.19 | 6,742,311.98 | -22,690,775.26 | 163,312,173.62 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-30 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |